NCT05527080 Development of Motility and Cognition in Infants
| NCT ID | NCT05527080 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helsinki University Central Hospital |
| Condition | Neurodevelopmental Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2021-10-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2021-10-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
PILKE study uses wearables for assessing motor development in infants in order to define functional growth trajectories in the normal infants and infants at risk of neurological compromise. In addition, PILKE studies correlation of early motor development to later neurocognitive development.
Eligibility Criteria
Inclusion Criteria: * age at enrollment 5-8mos * typically developing Exclusion Criteria: * all neurologically significant medical histories during pregnancy, at birth or postnatally * suspicion of developmental delay * suspicion or diagnosis of syndromes with neuromotor symptoms
Contact & Investigator
Sampsa K Vanhatalo, prof
PRINCIPAL INVESTIGATOR
University of Helsinki
Frequently Asked Questions
Who can join the NCT05527080 clinical trial?
This trial is open to participants of all sexes, aged 5 Months or older, up to 26 Months, studying Neurodevelopmental Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05527080 currently recruiting?
Yes, NCT05527080 is actively recruiting participants. Contact the research team at sampsa.vanhatalo@helsinki.fi for enrollment information.
Where is the NCT05527080 trial being conducted?
This trial is being conducted at Helsinki, Finland.
Who is sponsoring the NCT05527080 clinical trial?
NCT05527080 is sponsored by Helsinki University Central Hospital. The principal investigator is Sampsa K Vanhatalo, prof at University of Helsinki. The trial plans to enroll 250 participants.